EGFR and pancreatic neoplasm: Liposomal VP is currently being evaluated in patients with unresectable solid pancreatic tumors or advanced pancreatic cancer (NCT03033225), and patients with recurrent high‐grade EGFR‐mutated glioblastoma (NCT04590664) in a light‐independent manner.